12:10 PM EST - Nirvana Life Sciences Inc : Announces the development of a novel method of producing MDMA that greatly reduces manufacturing time. This 3-step synthesis, starting from the precursor safrole, takes as little as 24 hours to complete, depending upon which method of reduction of the ketone to the secondary amine is being used. This is approximately one third of the time that's required to complete current production methods using iso-safrole as an intermediate. Nirvana has filed an Application with the US Patent Office for this invention. Nirvana Life Sciences Inc
shares C.NIRV are trading -$0.04 at $0.27.
